Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06777368 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE

Study acronym: RESTORE
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Eligibility criteria expanded, about 7 words
    • Secondary endpoints: details revised at 2 of 13 entries
    • Site details revised at 8 of 71 sites
    • Study description expanded, about 2 words
  2. Primary completion moved earlier from Mar 2029 to Nov 2027
    • Study completion moved earlier from Jul 2033 to Nov 2027
    • Study sites: 70 to 71
    v22
  3. Study sites: 67 to 70v21
  4. Study sites: 65 to 67v20
  5. Study sites: 57 to 65v19
Show 17 earlier versionsHide 17 earlier versions
  1. Study sites: 56 to 57v18
  2. Study sites: 54 to 56v17
  3. Study sites: 53 to 54v16
  4. Study sites: 48 to 53v15
  5. Study sites: 47 to 48v14
  6. Study sites: 43 to 47v13
  7. Study sites: 42 to 43v12
  8. Study sites: 30 to 42v11
  9. Study sites: 23 to 30v10
  10. Study sites: 19 to 23v9
  11. Study sites: 14 to 19v8
  12. Study sites: 9 to 14v7
  13. Study sites: 4 to 9v6
  14. Start date changed from estimate of Feb 2025 to Feb 6, 2025v5
  15. Study sites: 3 to 4
    • Start date: Jan 2025 to Feb 2025
    v4
  16. Study sites: 1 to 3v3
  17. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to generate clinical evidence on valve safety and performance in subjects treated by redo Transcatheter Aortic Valve Replacement (TAVR).
Trial Details
NCT Number NCT06777368
Lead Sponsor Medtronic Cardiovascular
Conditions
(from sponsor)		 Aortic Stenosis
Related terms Aortic Valve Stenosis
Enrollment 225 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov